Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,869 | 40,031 | 9,565 | 18,986 | 5,153 |
| TOTAL | $27,905 | $41,368 | $10,453 | $20,110 | $5,610 |
| Non-Current Assets | |||||
| PPE Net | 979 | 1,023 | 1,090 | 894 | 337 |
| Other Non-Current Assets | 501 | 517 | 532 | 547 | 562 |
| TOTAL | $1,479 | $1,540 | $1,622 | $1,441 | $900 |
| Total Assets | $29,385 | $42,908 | $12,076 | $21,551 | $6,509 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,463 | 7,394 | 9,179 | 7,815 | 6,392 |
| Other current liabilities | 8,628 | 21,083 | 16,121 | 8,600 | N/A |
| TOTAL | $15,168 | $28,551 | $25,359 | $16,471 | $6,445 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,836 | 1,856 | 1,876 | 18,433 | 531 |
| TOTAL | $1,836 | $1,856 | $1,876 | $18,433 | $531 |
| Total Liabilities | $17,004 | $30,407 | $27,235 | $34,904 | $6,976 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,351 | 1,194 | 1,074 | 409 | 324 |
| Retained earnings | -230,322 | -229,403 | -202,761 | -210,034 | -196,302 |
| Other shareholders' equity | 7,844 | 17,068 | 0 | 0 | 0 |
| TOTAL | $12,381 | $12,501 | $-15,159 | $-13,353 | $-467 |
| Total Liabilities And Equity | $29,385 | $42,908 | $12,076 | $21,551 | $6,509 |